Diagnostic value of a novel fully automated immunochemistry assay for detection of ALK rearrangement in primary lung adenocarcinoma
Jianming Ying(Chinese Academy of Medical Sciences & Peking Union Medical College), Ning Lü(Hong Kong Baptist University), Lei Guo(Chinese Academy of Medical Sciences & Peking Union Medical College), Yun Ling(Zhejiang Chinese Medical University), Tian Qiu(Changi General Hospital), Ling Shan(Royal Netherlands Academy of Arts and Sciences), Xinyu Liu(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 126
Related Papers
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
|Journal of Thoracic Oncology|2020|415
Use of Mobile Health Applications for Health-Seeking Behavior Among US Adults
|Journal of Medical Systems|2016|220
Efficacy and safety of Paxlovid in severe adult patients with SARS-Cov-2 infection: a multicenter randomized controlled study
|The Lancet Regional Health - Western Pacific|2023|112
Consensus for HER2 alterations testing in non-small-cell lung cancer
|ESMO Open|2022|110